AbbVie (NYSE:ABBV) and AbCellera (NASDAQ:ABCL) have expanded their collaboration to include the discovery of T-cell
sanjeri/E+ via Getty Images SpringWorks Therapeutics (NASDAQ:SWTX) advanced 6.3% amid takeover speculation. The biotech firm
hapabapa Alector (NASDAQ:ALEC) said AbbVie (NYSE:ABBV) has sent written notice that it is terminating the
vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) said it expects to record an impairment charge
Bet_Noire/iStock via Getty Images Drugmakers have started 2025, implementing price hikes for 583 products within
Terminator3D/iStock via Getty Images Blockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly
jurgenfr AbbVie (NYSE:ABBV) said it now expects to report acquired IPR&D and milestone expenses of
PM Images The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) is up only 6.44% year-over-year, and
Summary: AbbVie offers a compelling investment opportunity after a recent price drop, combining dividend income,
hapabapa AbbVie (NYSE:ABBV) has agreed to acquire Roche (OTCQX:RHHBY) spinout Nimble Therapeutics for $200M upfront,